<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-01T07:47:25Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/13051" metadataPrefix="oai_dc">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/13051</identifier><datestamp>2024-04-16T17:14:34Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Ultrasound responsive Mesoporous Silica Nanoparticles for biomedical applications</dc:title>
   <dc:creator>Manzano García, Miguel</dc:creator>
   <dc:creator>Vallet Regí, María Dulce Nombre</dc:creator>
   <dc:subject>546</dc:subject>
   <dc:subject>615.46</dc:subject>
   <dc:subject>66</dc:subject>
   <dc:subject>Materiales</dc:subject>
   <dc:subject>Química inorgánica (Farmacia)</dc:subject>
   <dc:subject>3312 Tecnología de Materiales</dc:subject>
   <dc:description>RESEARCHER ID K-3719-2014 (Miguel Manzano García)
ORCID 0000-0001-6238-6111 (Miguel Manzano García)
RESEARCHER ID M-3378-2014 (María Vallet Regí)
ORCID 0000-0002-6104-4889 (María Vallet Regí)</dc:description>
   <dc:description>Nanotechnology, which has already revolutionised many technological areas, is expected to transform life sciences. In this sense, nanomedicine could address some of the most important limitations of conventional medicine. In general, nanomedicine include three major objectives: (1) trap and protect a great amount of therapeutic agents; (2) carry them to the specific site of disease avoiding any leakage; and (3) release on-demand high local concentrations of therapeutic agents. This feature article will make special emphasis on mesoporous silica nanoparticles that release their therapeutic cargo in response to ultrasound.</dc:description>
   <dc:description>Unión Europea. H2020</dc:description>
   <dc:description>Ministerio de Economía y Competitividad (MINECO)</dc:description>
   <dc:description>Depto. de Química en Ciencias Farmacéuticas</dc:description>
   <dc:description>Fac. de Farmacia</dc:description>
   <dc:description>TRUE</dc:description>
   <dc:description>inpress</dc:description>
   <dc:date>2023-06-17T13:19:15Z</dc:date>
   <dc:date>2023-06-17T13:19:15Z</dc:date>
   <dc:date>2019-01-23</dc:date>
   <dc:type>journal article</dc:type>
   <dc:identifier>https://hdl.handle.net/20.500.14352/13051</dc:identifier>
   <dc:identifier>1359-7345</dc:identifier>
   <dc:identifier>10.1039/C8CC09389J</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>VERDI (694160)</dc:relation>
   <dc:relation>MAT2015-64831-R</dc:relation>
   <dc:rights>open access</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Royal Society of Chemistry</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>